EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An adenovirus-based multiantigen vaccine protects against tuberculosis by coordinating adaptive immunity and curbing immunosuppressive mechanisms

Liqun Wei iD, Peng Wang, Ying Li, Xuejun Li, Xiaoling Shen, Furong He, Yingying Guo iD, Man Xing iD, Dongming Zhou iD

Microbiology Spectrum · 2026

DOI: 10.1128/spectrum.00907-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Liqun Wei und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathogen Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China. Hauptthemen laut MEDLINE: Tuberculosis Vaccines, Adaptive Immunity, Antigens, Bacterial, Mycobacterium tuberculosis. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Given that tuberculosis (TB) remains the leading cause of death from a single infectious agent, and that vaccination is the most effective control strategy, we systematically compared several vaccine construction strategies using a chimpanzee adenovirus vector platform. This led to the identification of a multi-antigen vaccine candidate, Ad-8 CP R2, as the most immunogenic construct. This candidate incorporates M. tuberculosis Ag85B, RpiB, and Rv2628 fused with the autophagy-inducing peptide C5 and Pan DR-binding epitope (PADRE) peptide. The C5 peptide in Ad-8 CP R2 vaccine enhanced the autophagic activity of antigen-presenting cells, thereby enhancing antigen presentation via the MHCI pathway and eliciting broad, multidimensional T-cell responses. Notably, Ad-8 CP R2 promoted the enrichment of tissue-resident memory T cells in the lungs, establishing local mucosal immunity that may restrict M. tuberculosis dissemination, while also generating antibodies capable of preventing M. tuberculosis infection. Furthermore, Ad-8 CP R2 limited the accumulation of myeloid-derived suppressor cells and alleviated T-cell exhaustion, thereby preserving adaptive immune function during chronic infection. Ultimately, we identified Th1 and Th17 responses, alongside functionally relevant antibodies, as key correlates of vaccine-induced protection. IMPORTANCE Current efforts in developing novel tuberculosis vaccines are to enhance the protective efficacy of vaccine candidates, with research primarily centered on rational vaccine design strategies for the generation of multivalent antigen constructs. In this context, we propose an approach involving the selection of M. tuberculosis antigenic proteins with strong immunogenicity and functional properties, which are then fused with peptide segments capable of augmenting antigen-specific immune responses. Delivery of these constructs via viral vector platforms induces robust and durable adaptive immunity. Such a strategy may further improve vaccine-mediated protection and could provide a theoretical foundation for developing next-generation tuberculosis vaccine candidates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tuberculosis VaccinesAdaptive ImmunityAntigens, BacterialMycobacterium tuberculosisAdenoviridaeTuberculosisAnimalsHumansGenetic VectorsMiceAcyltransferasesBacterial ProteinsAntibodies, Bacterial

Stichwörter der Autor:innen

M. tuberculosisT-cellantigen presentationautophagychimpanzee adenovirus vectormulti-antigen

Substanzen

Tuberculosis VaccinesAntigens, BacterialAcyltransferasesBacterial ProteinsAntibodies, Bacterial

Autor:innen und Institutionen

  • Department of Pathogen Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.
  • Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.

ORCID-Profile: Liqun Wei, Yingying Guo, Man Xing, Dongming Zhou

Förderung

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation

Zitieren

APA

Wei, L., Wang, P., Li, Y., Li, X., Shen, X., He, F., Guo, Y., Xing, M., & Zhou, D. (2026). An adenovirus-based multiantigen vaccine protects against tuberculosis by coordinating adaptive immunity and curbing immunosuppressive mechanisms. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00907-26

Vancouver

Wei L, Wang P, Li Y, Li X, Shen X, He F, et al. An adenovirus-based multiantigen vaccine protects against tuberculosis by coordinating adaptive immunity and curbing immunosuppressive mechanisms. Microbiology Spectrum. 2026. doi:10.1128/spectrum.00907-26

BibTeX
@article{Wei2026,
  author = {Wei, Liqun and Wang, Peng and Li, Ying and Li, Xuejun and Shen, Xiaoling and He, Furong and Guo, Yingying and Xing, Man and Zhou, Dongming},
  title = {An adenovirus-based multiantigen vaccine protects against tuberculosis by coordinating adaptive immunity and curbing immunosuppressive mechanisms},
  journal = {Microbiology Spectrum},
  year = {2026},
  doi = {10.1128/spectrum.00907-26}
}
Kostenlos starten →